Daniel Allar

""



Daniel joined TriMed’s Chicago editorial team in 2017 as a Cardiovascular Business writer. He previously worked as a writer for daily newspapers in North Dakota and Indiana.

LATEST ARTICLES BY THIS AUTHOR

Epinephrine after OHCA: Is the survival benefit worth the neurological risk?
Hypertension intervention shows promise at safety-net clinics
Pig undergoes 'tele-stenting' procedure with doc 100 miles away
Operator performs robot-assisted PCI from 100 miles away
Cardiology societies weigh in on TAVR volume requirements
How have pediatric VADs advanced and what’s next?
Prior marijuana use may boost hospital survival of AMI—but it’s complicated
Valve-in-valve TAVR outcomes favorable to native valve procedures
CVD deaths increasing in India; more than half of victims aren’t on meds
Less than 25% of HFrEF patients receive recommended drug doses